IP Library Granted Patent US 8,597,879
Granted Patent B2
US 8,597,879 · App. 12/575,703 · Granted Dec 3, 2013

Methods of characterizing small nucleic acid molecules

Inventors: Ronald W. Lennox (New York, NY); Colin W. Dykes (Gaithersburg, MD)
Assignee: Opgen, Inc.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,597,879
App. No.
12/575,703
Granted
Dec 3, 2013
Kind
B2
Abstract

The invention generally relates to methods of characterizing small nucleic acid molecules, such as plasmids or nucleic acid molecules obtained from a virus. In certain embodiments, the invention provides a method of characterizing a small circular nucleic acid molecule, the method including performing rolling circle amplification on a small circular nucleic acid molecule, thereby producing a concatamer, and generating an optical map of the concatamer, thereby characterizing the small circular nucleic acid molecule.

Claims (31)

1. A method of characterizing a nucleic acid molecule, the method comprising:

performing rolling circle amplification on a nucleic acid molecule of 1,000 base pairs or fewer, thereby producing a concatamer; and

generating an optical map of the concatamer, thereby characterizing the nucleic acid molecule.

2. The method according to claim 1 , wherein prior to said performing step, the method further comprises circularizing a nucleic acid molecule of 1,000 base pairs or fewer.

3. The method according to claim 1 , wherein the concatamer comprises at least five internal restriction sites.

4. The method according to claim 1 , wherein the nucleic acid molecule is DNA or RNA.

5. The method according to claim 1 , wherein the nucleic acid molecule is a plasmid.

6. The method according to claim 1 , wherein the nucleic acid molecule is obtained from a virus.

7. The method according to claim 1 , wherein the nucleic acid molecule is single-stranded.

8. The method according to claim 1 , wherein the nucleic acid molecule is double-stranded.

9. A method of characterizing a nucleic acid molecule, the method comprising:

circularizing a nucleic acid molecule of 1,000 base pairs or fewer to produce a circular nucleic acid molecule;

performing rolling circle amplification on the circular nucleic acid molecule, thereby producing a concatamer; and

generating an optical map of the concatamer, thereby characterizing the nucleic acid molecule.

10. The method according to claim 9 , wherein the concatamer comprises at least five internal restriction sites.

11. The method according to claim 9 , wherein the nucleic acid molecule is DNA or RNA.

12. The method according to claim 9 , wherein the nucleic acid molecule is obtained from a virus.

13. The method according to claim 9 , wherein the nucleic acid molecule is single-stranded.

14. The method according to claim 9 , wherein the nucleic acid molecule is double-stranded.

15. A method of characterizing a nucleic acid molecule, the method comprising:

performing rolling circle amplification on a nucleic acid molecule of 1,000 base pairs or fewer, thereby producing a concatamer;

depositing the concatamer onto a surface such that the concatamer is elongated and fixed on the surface so that the concatamer remains accessible for enzymatic reactions;

digesting the concatamer enzymatically to produce one or more restriction digests;

imaging the restriction digests; and

constructing an optical map from the restriction digests.

16. The method according to claim 15 , wherein prior to said performing step, the method further comprises circularizing a nucleic acid molecule of 1,000 base pairs or fewer.

17. The method according to claim 15 , wherein the concatamer comprises at least five internal restriction sites.

18. The method according to claim 15 , wherein the nucleic acid molecule is DNA or RNA.

19. The method according to claim 15 , wherein the surface is derivatized glass.

20. The method according to claim 15 , wherein the nucleic acid molecule is a plasmid.

21. The method according to claim 15 , wherein the nucleic acid molecule is obtained from a virus.

Assignments (3)
RELEASE OF SECURITY INTEREST Recorded Feb 3, 2021
From: MERCK GLOBAL HEALTH INNOVATION FUND, LLC
To: OPGEN, INC.; ADVANDX, INC.
Reel/Frame 055209/0242 →
SECURITY INTEREST Recorded Aug 17, 2015
From: OPGEN, INC.; ADVANDX, INC.
To: MERCK GLOBAL HEALTH INNOVATION FUND, LLC
Reel/Frame 036377/0129 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 3, 2009
From: LENNOX, RONALD W.; DYKES, COLIN W.
To: OPGEN, INC.
Reel/Frame 023598/0928 →
Continuity (1)
Related Publication 20110086344A1 · Apr 14, 2011